UK markets close in 2 hours 30 minutes

Akebia Therapeutics, Inc. (AX9.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.2740-0.0620 (-4.64%)
As of 08:02AM CEST. Market open.
Currency in EUR
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts6656
Avg. Estimate-0.33-0.29-1.59-0.78
Low estimate-0.42-0.44-1.83-1.12
High estimate-0.27-0.16-1.47-0.37
Year ago EPS-0.42-0.6-2.77-1.59
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts5566
Avg. Estimate47.31M54.39M208.77M272.86M
Low estimate35.1M45M193M224.32M
High estimate59.7M62.8M229.21M377.07M
Year ago sales59.99M56.7M295.31M208.77M
Sales growth (year/est)-21.10%-4.10%-29.30%30.70%
Earnings history30/09/202031/12/202031/03/202130/06/2021
Est. EPS-0.17-0.4-0.29-0.32
Actual EPS-0.42-0.6-0.45-0.51
Difference-0.25-0.2-0.16-0.19
Surprise %-147.10%-50.00%-55.20%-59.40%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.33-0.29-1.59-0.78
7 days ago-0.33-0.29-1.59-0.78
30 days ago-0.33-0.29-1.59-0.78
60 days ago-0.3-0.29-1.35-0.78
90 days ago-0.3-0.29-1.35-0.78
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesAX9.FIndustrySector(s)S&P 500
Current qtr.21.40%N/AN/AN/A
Next qtr.51.70%N/AN/AN/A
Current year42.60%N/AN/AN/A
Next year50.90%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A